TrialBlood2025
Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma.
Johannes Sam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
TrialBlood2025
Johannes Sam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.